Searched for
LEQSELVI FDA APPROVAL
New launches and R&D pipeline bolster Sun Pharma's long-term growth outlookSun Pharma reported robust global specialty growth and resilient domestic sales in Q3, despite US generics headwinds. Recent product launch...- Sun Pharma’s US innovative drug sales surpass generics for the first timeSun Pharma's U.S. innovative medicine sales have surpassed generics for the first time, driven by key products like Ilumya and Cequa. The l...
- Sun Pharma’s baldness drug Leqselvi debuts in US market after patent dispute settledSun Pharmaceutical Industries has reached a settlement agreement with Incyte Corporation concerning Leqselvi, a drug for severe hair loss, ...
- Sun Pharma shares rally 5% after US court lifts launch restrictions on autoimmune drugSun Pharma shares gained after a U.S. court lifted an injunction, clearing the way for the launch of LEQSELVI, its drug for autoimmune-rela...
- Stocks in news: TCS, Sun Pharma, Bharti Hexacom, Eternal, Greaves Cotton, Tata SteelTata Consultancy Services (TCS), India’s top software exporter, reported a 1.7% year-on-year decline in consolidated net profit to Rs 12,22...
Load More